...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Down 53% today

My brother is building a house in southern BC and he has dual citizenship. I'll see if there's a branch near him. 

Share
New Message
Please login to post a reply